What is Link Pharma Chem share price return in the past 10 years?

Link Pharma Chem Ltd share price has appreciated 16.1% annually (CAGR) over the past ten years.

Link Pharma Chem Ltd - Stock Valuation and Financial Performance

Name: Link Pharma Chem
Brand: Link Pharma Chem

BSE: 524748 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Link Pharma Chem Share Price

₹41.72 -0.93 -2.18%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Link Pharma Chem

Based on:

Data

M-Cap below 100cr DeciZen not available

ink Pharma Chem stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

39.33

Market Cap:

18.5 Cr.

52-wk low:

39.1

52-wk high:

55.7

Is Link Pharma Chem Ltd an attractive stock to invest in?

1. Is Link Pharma Chem Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Link Pharma Chem Ltd is a average quality company.

2. Is Link Pharma Chem Ltd undervalued or overvalued?

The key valuation ratios of Link Pharma Chem Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Link Pharma Chem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Link Pharma Chem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Link Pharma Chem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	-8.7%	9.8%	9.3%	15.4%	10.3%	12.9%	13.6%	16.6%	7.4%	-4.5%	-
Value Creation Index ⓘ	-1.6	-0.3	-0.3	0.1	-0.3	-0.1	0.0	0.2	-0.5	-1.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	17.6	12.3	16.1	23.5	24.5	25.5	34.8	53.6	38.8	29.9	30
Sales YoY Gr.	-	-29.8%	30.5%	46.2%	4.1%	4%	36.7%	53.9%	-27.6%	-22.9%	-
Adj EPS ⓘ	-4.9	-2.8	1.3	2.6	1.4	3.4	2.7	3.6	1.9	-3.2	1.1
YoY Gr.	-	NA	NA	96.2%	-45.1%	140%	-19.6%	34.8%	-48.4%	-270.2%	-
BVPS (₹) ⓘ	18.9	20.2	19.4	22.1	23.4	25.8	28.3	32.6	33.9	30.9	30.9
Adj Net Profit ⓘ	-2.2	-1.2	0.6	1.1	0.6	1.5	1.2	1.6	0.8	-1.4	0
Cash Flow from Ops. ⓘ	5.1	-3.9	2.2	3.8	1.4	3	4.8	-1.3	-1.7	0	-
Debt/CF from Ops. ⓘ	2.1	-1.4	2.1	0.7	1.9	1.2	0.8	-5.1	-5.1	-329.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.1%	4.1%	-4.9%	-22.9%
Adj EPS ⓘ	NA	-218%	-205.8%	-270.2%
BVPSⓘ	5.6%	5.7%	3%	-8.9%
Share Price	16.1%	28.8%	5.5%	-5.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-23.1	-14.3	6.6	12.3	6.2	13.7	10	12	5.7	-9.9	3.4
Op. Profit Mgn % ⓘ	-4.5	-1.3	15.8	11.8	8.2	13.4	9	6.5	7	-2.2	4.9
Net Profit Mgn % ⓘ	-12.5	-10	3.6	4.8	2.5	5.9	3.4	3	2.2	-4.8	1.6
Debt to Equity ⓘ	1.3	0.6	0.6	0.3	0.3	0.3	0.3	0.4	0.6	0.7	0
Working Cap Days ⓘ	164	200	148	111	115	117	108	92	161	199	91
Cash Conv. Cycle ⓘ	77	119	76	32	35	35	20	22	68	115	4

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 3.40%

Debt to equity has declined versus last 3 years average to 0.67

Sales growth has been subdued in last 3 years -4.94%

Net Profit has been subdued in last 3 years -205.83%

Sales growth is not so good in last 4 quarters at -9.27%

Latest Financials - Link Pharma Chem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1.1	-
TTM Sales (₹ Cr.)	29.6	-
BVPS (₹.) ⓘ	30.9	-
Reserves (₹ Cr.) ⓘ	9	-
P/BV ⓘ	1.35	-
PE ⓘ	39.33	-

From the Market
52 Week Low / High (₹)	39.10 / 55.71
All Time Low / High (₹)	0.84 / 75.00
Market Cap (₹ Cr.)	18.5
Equity (₹ Cr.)	4.4
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Link Pharma Chem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Link Pharma Chem

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Link Pharma Chem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	17.58	12.34	16.10	23.53	24.50	25.47	34.81	53.56	38.76	29.90
Operating Expenses ⓘ	18.36	12.50	14.08	20.76	22.48	22.87	31.85	50.36	36.45	30.55
Manufacturing Costs	3.36	3.35	3.75	4.32	4.85	6.10	6.86	6.29	7.11	6.54
Material Costs	10.92	4.84	5.45	9.90	11.33	9.91	17.78	36.43	21.37	16.68
Employee Cost	2.81	2.79	3.60	4.90	4.72	4.99	5.63	5.77	5.69	5.52
Other Costs ⓘ	1.27	1.53	1.28	1.64	1.59	1.87	1.58	1.86	2.29	1.81
Operating Profit ⓘ	-0.79	-0.16	2.02	2.78	2.02	2.60	2.97	3.20	2.31	-0.65
Operating Profit Margin (%)	-4.5%	-1.3%	12.5%	11.8%	8.2%	10.2%	8.5%	6.0%	6.0%	-2.2%
Other Income ⓘ	0.21	2.74	0.09	0.07	0.19	0.13	0.03	0.80	0.26	0.64
Interest ⓘ	1.44	0.91	0.80	0.62	0.39	0.36	0.44	0.45	0.76	0.87
Depreciation ⓘ	1.13	0.93	0.83	0.86	0.89	0.93	0.87	0.93	0.92	1.03
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-3.14	0.74	0.48	1.37	0.93	1.44	1.68	2.62	0.89	-1.92
Tax ⓘ	-0.94	0.15	0.26	0.24	0.27	0.49	0.59	0.74	0.23	-0.55
Profit After Tax	-2.20	0.59	0.23	1.13	0.66	0.95	1.08	1.88	0.65	-1.36
PAT Margin (%)	-12.5%	4.8%	1.4%	4.8%	2.7%	3.7%	3.1%	3.5%	1.7%	-4.6%
Adjusted EPS (₹)	-4.9	1.3	0.5	2.6	1.5	2.1	2.4	4.2	1.5	-3.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	8.37	8.96	8.60	9.79	10.38	11.43	12.56	14.47	15.04	13.71
Share Capital ⓘ	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44
Reserves ⓘ	3.93	4.52	4.16	5.35	5.94	6.99	8.12	10.03	10.60	9.27
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	9.92	5.08	4.50	2.43	2.36	3.17	3.16	5.49	7.77	8.88
Long Term Debt	5.76	1.75	1.18	2.25	1.71	3.17	3.16	2.90	1.98	1.06
Short Term Debt	4.16	3.32	3.32	0.19	0.66	0	0	2.58	5.79	7.82
Trade Payables	2.83	1.08	3.03	3.37	3.37	3.01	6.85	4.53	6.61	1.76
Others Liabilities ⓘ	5.11	2.43	1.01	1.60	1.89	1.36	3.47	4.48	3.04	1.61
Total Liabilities ⓘ	26.23	17.55	17.14	17.19	18	18.97	26.04	28.96	32.46	25.95
Fixed Assets
Gross Block	23.68	15.13	10.40	11.43	11.58	11.56	11.74	12.74	13.88	15.66
Accumulated Depreciation	6.17	4.99	0.83	1.67	2.45	2.76	3.03	3.95	4.88	5.73
Net Fixed Assetsⓘ	17.51	10.13	9.57	9.76	9.14	8.81	8.71	8.79	9	9.94
CWIP ⓘ	0	0	0	0.01	0.43	0	0	0.21	0	0
Investmentsⓘ	0.02	0.02	0.03	0.03	0.03	0.03	0.03	4.52	3.64	2.93
Inventories	3.75	3.67	4.27	2.63	2.87	1.63	2.50	4.76	12.25	6.21
Trade Receivables	3.07	2.33	2.18	3.18	3.04	4.99	5.55	5.37	3.63	5.15
Cash Equivalents	1.21	0.27	0.18	0.18	0.20	2.05	4.86	0.88	0.20	0.09
Others Assetsⓘ	0.67	1.13	0.92	1.39	2.30	1.45	4.40	4.45	3.74	1.63
Total Assets ⓘ	26.23	17.55	17.14	17.19	18	18.97	26.04	28.96	32.46	25.95

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	5.13	-3.91	2.23	3.79	1.36	2.95	4.84	-1.26	-1.71	-0.03
PBT ⓘ	-3.14	0.74	0.48	1.37	0.93	1.44	1.68	2.62	0.89	-1.92
Adjustment ⓘ	-0.42	-0.43	2.13	1.47	1.26	2.04	1.46	0.96	2.25	1.33
Changes in Working Capital ⓘ	8.68	-4.12	-0.28	1.25	-0.63	-0.64	2.18	-4.16	-4.43	0.93
Tax Paid ⓘ	0	-0.10	-0.10	-0.30	-0.20	0.11	-0.48	-0.67	-0.41	-0.37
Cash Flow From Investing Activity ⓘ	-3.27	8.72	-0.73	-1.15	-0.96	-1.66	-2.16	-4.97	-0.08	0.41
Capex	-3.29	8.71	-0.86	-1.16	-0.87	-1.68	-1.70	-0.74	-0.89	-0.83
Net Investments	0	0	0.10	0.01	-0.09	-0.05	-0.45	-4.32	0.67	1.15
Others ⓘ	0.02	0.02	0.03	0	0	0.07	-0.01	0.10	0.15	0.08
Cash Flow From Financing Activityⓘ	-0.87	-5.75	-1.48	-2.63	-0.46	0.55	-0.33	2.27	1.61	-0.41
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0.14	-0.84	-1.56
Interest Paid ⓘ	-1.44	-0.91	-0.80	-0.62	-0.39	-0.36	-0.44	-0.45	-0.76	-0.87
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.56	-4.84	-0.68	-2.02	-0.07	0.91	0.11	2.58	3.20	2.03
Net Cash Flow ⓘ	0.99	-0.94	0.02	0	-0.05	1.85	2.35	-3.95	-0.17	-0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-23.07	6.83	2.58	12.34	6.53	8.71	9.04	13.92	4.43	-9.48
ROCE (%)	-8.74	9.83	9.26	15.38	10.31	12.87	13.58	16.57	7.38	-4.47
Asset Turnover Ratio	0.72	0.61	1.03	1.4	1.39	1.38	1.55	1.95	1.26	1.02
PAT to CFO Conversion(x)	N/A	-6.63	9.7	3.35	2.06	3.11	4.48	-0.67	-2.63	N/A
Working Capital Days
Receivable Days	61	74	46	41	46	58	55	37	42	54
Inventory Days	88	101	81	53	41	32	22	25	80	113
Payable Days	118	147	138	118	109	118	101	57	95	92

Link Pharma Chem Ltd Stock News

Link Pharma Chem Ltd FAQs

What is the share price of Link Pharma Chem?

Company share prices are keep on changing according to the market conditions. The closing price of Link Pharma Chem on 20-Dec-2024 16:59 is ₹41.72.

What is the market cap of Link Pharma Chem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Link Pharma Chem stood at ₹18.53.

What is the P/E ratio of Link Pharma Chem?

The latest P/E ratio of Link Pharma Chem as of 20-Dec-2024 16:59 is 39.33.

What is the P/B ratio of Link Pharma Chem?

The latest P/B ratio of Link Pharma Chem as of 20-Dec-2024 16:59 is 1.35.

What is the 52-week high and low of Link Pharma Chem?

The 52-week high of Link Pharma Chem is ₹55.71 and the 52-week low is ₹39.10.

What is the TTM revenue of Link Pharma Chem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Link Pharma Chem is ₹29.61 ( Cr.) .

About Link Pharma Chem Ltd

Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA. In FY08, the company received an international grant from United Nations Industrial Development Organization of Rs 7.7 million for phasing out a carbon tetra chloride product as raw material, which was implemented. The company plans to develop the acquired land in the Baroda district and has purchased a 10,800 sq. m. plot with RCC building of approximately 50,000 sq. ft. constructed area from DRT Ahmedabad for Rs 14 million for diversification projects.

Link Pharma Chem has, over the years, followed the best business practices. The company believes that good corporate governance is essential to achieve long-term corporate goals and to enhance stakeholders' value. In this pursuit, the company is committed to conducting business in accordance with the highest legal and ethical standard, superior product quality and services to its customers. All employees are bound by a code of conduct, which sets forth the company's policies on important issues, including relationship with customers, vendors and the government.

Business areas of the company:

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA.